US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts
The tariffs, set to increase significantly from August 2029, could impact affordable medicine access. Experts emphasise strengthening domestic manufacturing while preserving global supply chain integration.
Leave a Comment